Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 9/20 | 0.69 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | POLB | P06746 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | RORC | P51449 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19631412 | 0.89 | DHODH (0.81) | DHODHMAPTPOLBPKMKDM4E | |
| SCHEMBL20956439 | 0.89 | DHODH (0.81) | DHODHMAPTPOLBPKMKDM4E | |
| SCHEMBL29911511 | 0.89 | DHODH (0.81) | DHODHMAPTPOLBPKMKDM4E | |
| SCHEMBL19631366 | 0.82 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL30131181 | 0.82 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL19631383 | 0.81 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL30131137 | 0.81 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL19631451 | 0.80 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL30131171 | 0.80 | DHODH (1.00) | DHODHMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL25614244 | 0.80 | DHODH (0.76) | DHODHMAPTKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | SARS1, EIF2AK2, NSUN3 | DHODH 2268/4885MAPT 1783/4885POLB 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.